EUVIMEDEUVIMED entdecken
EvaluationsstudieOpen Access · CC BY 4.0

A fluorogenic biotracer for reliable detection of staphylococcal beta-lactamase: towards improved precision therapy in severe MSSA infections

Céline Dupieux iD, Patricia Martins Simoes, Benjamin Youenou iD, François Vandenesch, Anne Tristan iD, Frédéric Laurent

Journal of Antimicrobial Chemotherapy · 04.08.2026 · 81 (9)

DOI: 10.1093/jac/dkag268 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 14.08.2026. Verfasst von Céline Dupieux und 5 weiteren Autor:innen. Beteiligte Einrichtung: French National Reference Centre for Staphylococci, Institut des Agents Infectieux, Hospices Civils de Lyon, Lyon, France. Hauptthemen laut MEDLINE: beta-Lactamases, Staphylococcus, Staphylococcal Infections, Fluorescent Dyes. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MOLSID.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and objectives Accurate detection of staphylococcal beta-lactamase remains a diagnostic challenge, despite its importance for guiding antibiotic therapy, particularly in severe infections, such as endocarditis and bacteraemia. Currently, no available method reliably detects beta-lactamase activity in all staphylococcal species. Here, we evaluated a novel fluorogenic biotracer, 352600-C (MOLSID, Lyon, France), designed to detect beta-lactamase activity in staphylococci.

Methods

The 352600-C biotracer was incorporated into Mueller–Hinton agar plates onto which staphylococcal strains were subcultured at 37°C. Colony fluorescence was assessed at 4, 6 and 24 h using a 365 nm UV lamp. The assay was performed on a large collection of blaZ-positive (n = 124, including BlaZ types A, B, C and D) and blaZ-negative (n = 69) staphylococci from 18 species (Staphylococcus aureus, n = 100; S. non-aureus, n = 93). Molecular detection of the blaZ gene using WGS served as the gold standard. Phenotypic susceptibility to penicillins was also tested using EUCAST recommendations.

Results

After 4, 6 and 24 h of incubation, the assay showed sensitivities of 92.2%, 96.9% and 100% for S. aureus and 50.0%, 88.3% and 100% for non-aureus staphylococci, respectively. None of the 69 blaZ-negative strains produced fluorescent colonies (specificity 100%). Notably, the assay detected all BlaZ types. Penicillin disc diffusion showed 98.4% sensitivity and 77.8% specificity for MSSA.

Conclusions

This novel assay for the detection of staphylococcal beta-lactamase demonstrated simplicity, rapidity and excellent accuracy after 24 h incubation (100% sensitivity and specificity) across a genetically diverse and representative collection of clinical isolates, making it a valuable tool for routine diagnostics and antimicrobial stewardship.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-LactamasesStaphylococcusStaphylococcal InfectionsFluorescent DyesHumansAnti-Bacterial AgentsMicrobial Sensitivity TestsSensitivity and SpecificityStaphylococcus aureus

Substanzen

beta-LactamasesAnti-Bacterial AgentsFluorescent Dyes

Autor:innen und Institutionen

  • French National Reference Centre for Staphylococci, Institut des Agents Infectieux, Hospices Civils de Lyon, Lyon, France.
  • Centre for Integrative Research in Infectious Diseases and Immunology, Inserm U1111, CNRS UMR5308, ENS de Lyon, Université Lyon 1, Lyon, France.

ORCID-Profile: Céline Dupieux, Benjamin Youenou, Anne Tristan

Förderung

  • MOLSID

Zitieren

APA

Dupieux, C., Martins Simoes, P., Youenou, B., Vandenesch, F., Tristan, A., & Laurent, F. (2026). A fluorogenic biotracer for reliable detection of staphylococcal beta-lactamase: towards improved precision therapy in severe MSSA infections. Journal of Antimicrobial Chemotherapy, 81(9). https://doi.org/10.1093/jac/dkag268

Vancouver

Dupieux C, Martins Simoes P, Youenou B, Vandenesch F, Tristan A, Laurent F. A fluorogenic biotracer for reliable detection of staphylococcal beta-lactamase: towards improved precision therapy in severe MSSA infections. Journal of Antimicrobial Chemotherapy. 2026;81(9). doi:10.1093/jac/dkag268

BibTeX
@article{Dupieux2026,
  author = {Dupieux, Céline and Martins Simoes, Patricia and Youenou, Benjamin and Vandenesch, François and Tristan, Anne and Laurent, Frédéric},
  title = {A fluorogenic biotracer for reliable detection of staphylococcal beta-lactamase: towards improved precision therapy in severe MSSA infections},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2026},
  volume = {81},
  number = {9},
  doi = {10.1093/jac/dkag268}
}
Kostenlos starten →